Hemostasis

As a pharmaceutical manufacturer and global supplier, Grand Life Sciences develops, manufactures and sells a variety of Hemostatic Products, including Hemocoagulase Bothrops Atrox, Tranexamic Acid Injection, Oxytocin Injection, Terlipressin for Injection, and provide different solutions for Coagulation System and fibrinolysis system.

One critical aspect of patient care is the effective management of bleeding, especially in surgical and trauma scenarios. Grand Life Sciences (Liaoning) Co., Ltd., a leading pharmaceutical manufacturer, has been at the forefront of developing cutting-edge hemostatic products that address the diverse needs of healthcare professionals.

Hemostasis, the body's natural process of preventing and stopping bleeding, is a complex and intricate system involving platelets, blood vessels, and proteins. Disruptions in this delicate balance can lead to excessive bleeding or clotting, posing significant risks to patients undergoing surgical procedures or experiencing traumatic injuries. Recognizing the critical importance of maintaining hemostasis, we have dedicated extensive research and resources to develop a range of hemostatic products tailored to various medical scenarios, including Hemocoagulase Bothrops Atrox, Tranexamic Acid Injection, Oxytocin Injection, Terlipressin for Injection.

Ensuring the safety and efficacy of hemostatic products is paramount to us. The company adheres to stringent regulatory standards and quality assurance protocols throughout the manufacturing process. We are proud to be certified by NMPA, affirming its commitment to delivering products that meet the highest industry standards.

Stringent quality control measures, from raw material sourcing to final product distribution, guarantee the consistency and reliability of our hemostatic products. By prioritizing regulatory compliance and quality assurance, GLS instills confidence in healthcare professionals who rely on its products for critical patient care.